The Harvest Diversified Monthly Income ETF is built to deliver the consistent monthly income and diverse growth opportunities that Harvest ETFs are known for.

Lexaria Bioscience is setting new standards in drug delivery with its patented DehydraTECH™ oral technology, optimizing absorption for GLP-1 and other high-demand drugs.

On FOX Business News broadcast on Sunday, Dec 1, 2024 – BTV Business Television interviews emerging companies in the markets including:

Lexaria Bioscience’s DehydraTECH™ technology aims to redefine oral drug delivery, focusing on faster absorption and improved efficacy, with a promising impact on the GLP-1 pharmaceutical market.